D
David P. J. Turner
Researcher at University of Nottingham
Publications - 47
Citations - 2694
David P. J. Turner is an academic researcher from University of Nottingham. The author has contributed to research in topics: Neisseria meningitidis & Medicine. The author has an hindex of 22, co-authored 41 publications receiving 1719 citations. Previous affiliations of David P. J. Turner include Nottingham University Hospitals NHS Trust.
Papers
More filters
Journal ArticleDOI
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial.
Katherine R. W. Emary,Tanya Golubchik,Parvinder K. Aley,Cristina V. Ariani,Brian Angus,S Bibi,Beth Blane,David Bonsall,P Cicconi,Sue Charlton,Elizabeth A. Clutterbuck,Andrea M. Collins,Tony Cox,Thomas C. Darton,Christina Dold,Alexander D. Douglas,Christopher J A Duncan,Christopher J A Duncan,Katie J. Ewer,Amy Flaxman,Saul N. Faust,Saul N. Faust,Daniela M. Ferreira,Shuo Feng,Adam Finn,P M Folegatti,Michelle Fuskova,Eva P. Galiza,Anna L. Goodman,Anna L. Goodman,Catherine M. Green,Christopher A Green,Melanie Greenland,Bassam Hallis,Paul T. Heath,Jodie Hay,Helen Hill,D Jenkin,Simon Kerridge,Rajeka Lazarus,Vincenzo Libri,Patrick J. Lillie,Catherine Ludden,N G Marchevsky,Angela M. Minassian,Alastair McGregor,Yama F Mujadidi,Daniel J. Phillips,Emma Plested,Katrina M Pollock,Hannah Robinson,Andrew Smith,R Song,Matthew D. Snape,Rebecca K. Sutherland,E. Thomson,E. Thomson,Mark Toshner,David P. J. Turner,David P. J. Turner,Johan Vekemans,Tonya Villafana,Christopher Williams,Christopher Williams,Adrian V. S. Hill,Teresa Lambe,Sarah C. Gilbert,Merryn Voysey,M N Ramasamy,Andrew J. Pollard +69 more
TL;DR: A post-hoc analysis of the efficacy of the adenoviral vector vaccine, ChAdOx1 nCoV-19 (AZD1222), against B.1.7, emerged as the dominant cause of COVID-19 disease in the UK from November, 2020 as discussed by the authors.
Journal ArticleDOI
Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial.
Xinxue Liu,Robert Shaw,Arabella Stuart,Melanie Greenland,Parvinder K. Aley,Nick Andrews,J. Claire Cameron,Sue Charlton,Elizabeth A. Clutterbuck,Andrea M. Collins,Tanya Dinesh,Anna England,Saul N. Faust,Saul N. Faust,Daniela M. Ferreira,Adam Finn,Christopher A Green,Bassam Hallis,Paul T. Heath,Helen Hill,Teresa Lambe,Rajeka Lazarus,Vincenzo Libri,Fei Long,Yama F Mujadidi,Emma Plested,Samuel Provstgaard-Morys,M N Ramasamy,Mary Ramsay,Robert C. Read,Robert C. Read,Hannah Robinson,Nisha Singh,David P. J. Turner,David P. J. Turner,Paul Turner,Laura L. Walker,Rachel White,Jonathan S. Nguyen-Van-Tam,Matthew D. Snape,Alasdair Munro,Jazz Bartholomew,Laura Presland,Sarah Horswill,Sarah Warren,Sophie Varkonyi-Clifford,Stephen Saich,Kirsty Adams,Marivic Ricamara,Nicola Turner,Nicole Y Yee Ting,Sarah Whittley,Tommy Rampling,Amisha Desai,Claire Brown,Ehsaan Qureshi,Karishma Gokani,Kush Naker,Johanna K Kellett Wright,Rachel Williams,Tawassal Riaz,Florentina D Penciu,Claudio Di Maso,E Howe,Iason Vichos,Mujtaba Ghulam Farooq,Rabiullah Noristani,Xin L Yao,Neil J. Oldfield,Daniel Hammersley,Sue Belton,Simon Royal,Alberto San Francisco Ramos,Cecilia Hultin,Eva P. Galiza,Farah Shiham,Carla Solórzano,Hannah Sainsbury,Kelly Davies,Pauline Ambrose,Lisa Hitchins,Natalie Baker,Stephanie Leung,Ross Fothergill,Kerry Godwin,Karen Buttigieg,Imam Shaik,Phill Brown,Chanice Knight,Paminder Lall,Lauren Allen +90 more
TL;DR: The Com-COV trial as discussed by the authors evaluated vaccine safety, reactogenicity, and immunogenicity of the BNT/ChAd schedule with a 28-day or 84-day prime-boost interval.
Journal ArticleDOI
Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial
Robert C. Read,David Baxter,David Chadwick,Saul N. Faust,Saul N. Faust,Adam Finn,Stephen B. Gordon,Paul T. Heath,David J. M. Lewis,Andrew J. Pollard,David P. J. Turner,Rohit Bazaz,Amitava Ganguli,Tom Havelock,Tom Havelock,Keith R. Neal,Ifeanyichukwu O Okike,Begonia Morales-Aza,Kamlesh Patel,Matthew D. Snape,John Williams,Stefanie Gilchrist,Steve J. Gray,Martin C. J. Maiden,Daniela Toneatto,Huajun Wang,Maggie McCarthy,Peter M. Dull,Ray Borrow,Ray Borrow +29 more
TL;DR: Although there was no significant difference between groups at 1 month after vaccine course, MenACWY-CRM and 4CMenB vaccines reduced meningococcal carriage rates during 12 months after vaccination and therefore might affect transmission when widely implemented.
Journal ArticleDOI
Clinical Impact of Antimicrobial Resistance in European Hospitals: Excess Mortality and Length of Hospital Stay Related to Methicillin-Resistant Staphylococcus aureus Bloodstream Infections
Marlieke E. A. de Kraker,Martin Wolkewitz,Peter Davey,Walter Koller,Jutta Berger,Jan Nagler,Claudine Icket,Smilja Kalenić,Jasminka Horvatić,Harald Seifert,Achim J. Kaasch,O. Paniara,Athina Argyropoulou,Maria Bompola,Edmond Smyth,Mairead Skally,Annibale Raglio,Uga Dumpis,Agita Melbarde Kelmere,Michael Borg,Deborah Xuereb,Mihaela C. Ghita,Michelle Noble,Jana Kolman,Stanko Grabljevec,David P. J. Turner,Louise Lansbury,Hajo Grundmann +27 more
TL;DR: Irrespective of methicillin susceptibility, S. aureus BSI has a significant impact on morbidity and mortality and in addition, MRSA BSI leads to a fatal outcome more frequently than MSSA B SI.
Journal ArticleDOI
Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002).
Amy Flaxman,N G Marchevsky,D Jenkin,J Aboagye,Parvinder K. Aley,Brian Angus,Sandra Belij-Rammerstorfer,S Bibi,M Bittaye,Federica Cappuccini,P Cicconi,Elizabeth A. Clutterbuck,Sophie Davies,Wanwisa Dejnirattisai,Christina Dold,Katie J. Ewer,P M Folegatti,Jamie Fowler,Adrian V. S. Hill,Simon Kerridge,Angela M. Minassian,Juthathip Mongkolsapaya,Yama F Mujadidi,Emma Plested,M N Ramasamy,Hannah Robinson,Helen Sanders,Emma V. Sheehan,Holly Smith,Matthew D. Snape,R Song,Danielle Woods,Gavin R. Screaton,Sarah C. Gilbert,Merryn Voysey,Andrew J. Pollard,Teresa Lambe,Syed Adlou,Robert Aley,Aabidah Ali,Rachel Anslow,Megan Baker,Phillip Baker,Jordan R. Barrett,Louise Bates,Kirsten Beadon,Rebecca Beckley,Jonathan Bell,D Bellamy,Amy Beveridge,Cameron Bissett,Luke Blackwell,Heather Bletchly,Amy Boyd,Alice Bridges-Webb,Charles H. Brown,Nicholas Byard,Susana Camara,Liliana Cifuentes Gutierrez,Andrea M. Collins,Rachel Cooper,Wendy E.M. Crocker,Thomas C. Darton,Hannah Davies,Judith Davies,Tesfaye Demissie,Claudio Di Maso,Tanya Dinesh,Francesca R. Donnellan,Alexander D. Douglas,Rachael Drake-Brockman,Christopher J A Duncan,Sean C. Elias,Katherine R. W. Emary,Mutjaba Ghulam Farooq,Saul N. Faust,Sally Felle,Daniela M. Ferreira,Carla Ferreira Da Silva,Adam Finn,Karen J. Ford,Emma Francis,Julie Furze,Michelle Fuskova,Eva P. Galiza,Ana Gibertoni Cruz,Leila Godfrey,Anna L. Goodman,Catherine M. Green,Christopher A Green,Nicola Greenwood,Daisy Harrison,Thomas C. Hart,Sophia Hawkins,Paul T. Heath,Helen Hill,Kushalinii Hillson,Bryn Horsington,Mimi M. Hou,E Howe,Nicola Howell,Carina Citra Dewi Joe,Elizabeth F Jones,Mwila Kasanyinga,Jade Keen,Sarah Kelly,David J. Kerr,Liaquat Khan,Baktash Khozoee,Jasmin Kinch,Patrick Kinch,Stanislava Koleva,Jonathan Kwok,Colin W. Larkworthy,Alison M. Lawrie,Rajeka Lazarus,Emily A. Lees,Grace Li,Vincenzo Libri,Patrick J. Lillie,Aline Linder,Fei Long,Raquel Lopez Ramon,Reece Mabbett,R Makinson,Spyridoula Marinou,Emma Marlow,Julia L. Marshall,O Mazur,Joanne McEwan,Alastair McGregor,Jolynne Mokaya,Ella Morey,Gertraud Morshead,Richard Morter,Jilly Muller,Philomena Mweu,Rabiullah Noristani,Nelly Owino,Marco Polo Peralta Alvarez,Abigail Platt,Katrina M Pollock,Ian D. Poulton,Samuel Provstgaard-Morys,David Pulido-Gomez,Matthew Rajan,Fernando Ramos Lopez,Adam J. Ritchie,Hannah Roberts,Christine S. Rollier,Indra Rudiansyah,Katherine Sanders,Jack E. Saunders,Samiullah Seddiqi,Hannah Sharpe,Robert Shaw,L Silva-Reyes,Nisha Singh,David J. Smith,Catherine C. Smith,Andrew Smith,Alexandra J. Spencer,Arabella Stuart,Rebecca K. Sutherland,Anna Szigeti,Karly Tang,Merin Thomas,Tonia M. Thomas,Amber Thompson,E. Thomson,Estée M. Török,Mark Toshner,Nguyen Tran,Rose Trivett,Iain Turnbull,Cheryl Turner,David P. J. Turner,Marta Ulaszewska,Iason Vichos,Laura L. Walker,Marion E. Watson,Conor Whelan,Rachel White,Sarah Williams,Chris Williams,Daniel B. Wright,Andy Yao +186 more
TL;DR: In this paper, the authors assessed the persistence of immunogenicity after a single dose of ChAdOx1 nCoV-19 (AZD1222), immunity after an extended interval (44-45 weeks) between the first and second dose, and response to a third dose as a booster given 28-38 weeks after the second dose.